Nature`s Sunshine Products EBIT

As of the most recent data (June 2026), NATR shows a EBIT of $15M. That compares with $18M in the prior-year period — down 15.4% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NATR's EBIT is now $15M (was $18M) — a 15.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nature`s Sunshine Products is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Nature`s Sunshine Products is at $15M, which is lower that average. That is roughly 99.9% below the sector mean. Use the comparison chart on this page to see how NATR stacks up against individual peers as well.

Tracking NATR's ebit over time shows whether Nature`s Sunshine Products is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $18M in the prior-year period — down 15.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Nature`s Sunshine Products's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $15M) with ownership activity and broader fundamentals.